Publicación:
Atrofia inflamatoria proliferativa: potencial lesión precursora de adenocarcinoma prostático

dc.contributor.authorBenedetti Padrón, Inésspa
dc.contributor.authorReyes, Niradizspa
dc.date.accessioned2014-01-15 00:00:00
dc.date.available2014-01-15 00:00:00
dc.date.issued2014-01-15
dc.format.mimetypeapplication/pdfspa
dc.identifier.doi10.32997/rcb-2014-2892
dc.identifier.eissn2389-7252
dc.identifier.issn2215-7840
dc.identifier.urihttps://hdl.handle.net/11227/13119
dc.identifier.urlhttps://doi.org/10.32997/rcb-2014-2892
dc.language.isospaspa
dc.publisherUniversidad de Cartagenaspa
dc.relation.bitstreamhttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/download/2892/2435
dc.relation.citationeditionNúm. 1 , Año 2014spa
dc.relation.citationendpage99
dc.relation.citationissue1spa
dc.relation.citationstartpage88
dc.relation.citationvolume5spa
dc.relation.ispartofjournalRevista Ciencias Biomédicasspa
dc.relation.referencesShen MM, Abate-Shen M. Molecular genetics of prostate cancer: new prospects for old challenges. Genes & development. 2010;24(18):1967-2000.spa
dc.relation.referencesDe Marzo AM, Nakai Y, Nelson WG. Inflammation, atrophy, and prostate carcinogenesis. Urologic Oncology. 2007;25(5):398-400.spa
dc.relation.referencesDe Marzo AM, Platz E, Sutcliffe S, Xu J, Grönberg H, Dracke CH, et al. Inflammation in prostate carcinogenesis. Nature reviews. Cancer. 2007; 7(4): 256-69.spa
dc.relation.referencesReyes I, Reyes N, Iatropoulos M, Mittelman A, Geliebter J. Aging-associated changes in gene expression in the ACI rat prostate: Implications for carcinogenesis. The Prostate. 2005; 63(2):169-86.spa
dc.relation.referencesSfanos KS, De Marzo AM. Prostate cancer and inflammation: the evidence. Histopathology. 2012; 60(1):199-215.spa
dc.relation.referencesReyes N, Iatropoulos M, Mittelman A, Geliebter J. Microarray analysis of diet-induced alterations in gene expression in the ACI rat prostate. Eur J Cancer Prev. 2002. 11 Suppl 2: S37-42.spa
dc.relation.referencesDe Marzo AM, Meeker AK, Zha S, Luo J, Nakayama M, Platz EA, et al. Human prostate cancer precursors and pathobiology. Urology. 2003. 62(5 Suppl1): 55-62.spa
dc.relation.referencesDe Nunzio C, Kramer G, Marberger M, Montironi R, Nelson W, Schröder, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. European Urology. 2011. 60(1):106-17.spa
dc.relation.referencesGurel B, Iwata T, Koh CH, Yegnasubramanian S, Nelson WG, De Marzo AM. Molecular alterations in prostate cancer as diagnostic, prognostic, and therapeutic targets. Adv Anat Pathol. 2008.15(6):319-31.spa
dc.relation.referencesNelson WG, De Marzo AM, Isaacs WS. Prostate cancer. N Engl J Med. 2003. 349(4):366-81.spa
dc.relation.referencesVis AN, Van Der Kwast TH H. Prostatic intraepithelial neoplasia and putative precursor lesions of prostate cancer: a clinical perspective. BJU international. 2001; 88(2):147-57.spa
dc.relation.referencesKlink JC, Miocinovic R, Galluzzi CM, Klein E. High-grade prostatic intraepithelial neoplasia. Korean J Urol, 2012. 53(5):297-303.spa
dc.relation.referencesBostwick DG, Cheng L. Precursors of prostate cancer. Histopathology. 2012. 60(1):4-27.spa
dc.relation.referencesBostwick DG, Liu L, Brawer M, Qian J. High-grade prostatic intraepithelial neoplasia. Rev Urol. 2004. 6(4):171-9.spa
dc.relation.referencesDe Marzo, Platz EA, Epstein JI, Ali T, Billis A, Chan TY. A working group classification of focal prostate atrophy lesions. Am J Surg Pathol. 2006. 30(10):1281-91.spa
dc.relation.referencesDe Marzo AM, Marchi VL, Epstein JI, Nelson WG. Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis. Am J Pathol. 1999;155(6):1985-92.spa
dc.relation.referencesPutzi MJ, De Marzo AM. Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia. Urology. 2000; 56(5): 828-32.spa
dc.relation.referencesBillis A. Prostatic atrophy. Clinicopathological significance. Int Braz J Urol. 2010; 36(4):401-9.spa
dc.relation.referencesAmin MB, Tamboli P, Varma M, Srigley JR. Postatrophic hyperplasia of the prostate gland: a detailed analysis of its morphology in needle biopsy specimens. American Journal of Surgical Pathology. 1999;23(8):925-31.spa
dc.relation.referencesMcNeal JE. Prostate. En: Sternberg SS, ed. Histology for Pathologists. Philadelphia: Lippincott-Raven; 1997. p. 997–1017.spa
dc.relation.referencesMontironi R, Mazzucchelli R, Lopez-Beltran A, Cheng L, Scarpelli M. Mechanisms of disease: high-grade prostatic intraepithelial neoplasia and other proposed preneoplastic lesions in the prostate. Nature Reviews Urology. 2007;4(6): 321-32.spa
dc.relation.referencesDe Marzo AM, Putzi MJ, Nelson WG. New concepts in the pathology of prostatic epithelial carcinogenesis. Urology. 2001; 57(4 Suppl 1):103-14.spa
dc.relation.referencesWang W, Bergh A, Damber JE. Morphological transition of proliferative inflammatory atrophy to high-grade intraepithelial neoplasia and cancer in human prostate. The Prostate. 2009; 69(13):1378-86.spa
dc.relation.referencesShah R, Mucci N, Amin A, Macoska JA, Rubin MA. Postatrophic hyperplasia of the prostate gland: neoplastic precursor or innocent bystander? Am J Pathol. 2001;158(5):1767-73.spa
dc.relation.referencesAnton RC, Kattan MW, Chakraborty S, Wheeler TM. Postatrophic hyperplasia of the prostate: lack of association with prostate cancer. Am J Pathol.1999;23(8): 932-6.spa
dc.relation.referencesBillis A. Prostatic atrophy: an autopsy study of a histologic mimic of adenocarcinoma. Mod Pathol. 1998;11(1):47-54.spa
dc.relation.referencesBillis A, Magna LA. Inflammatory atrophy of the prostate. Prevalence and significance. Archives of Pathology & Laboratory Medicine. 2003; 127(7):840-4.spa
dc.relation.referencesFranks LM. Atrophy and hyperplasia in the prostate proper. J Pathology and bacteriology. 1954; 68(2):617-21.spa
dc.relation.referencesLiavag I. The localization of prostatic carcinoma. An autopsy study. Scandinavian J Urology and Nephrology. 1968;2(2):65-71.spa
dc.relation.referencesRuska KM, Sauvageot J, Epstein JI. Histology and cellular kinetics of prostatic atrophy. Am J Surg Pathol. 1998; 22(9):1073-7.spa
dc.relation.referencesvan Leenders GJ, Gage WR, Hicks JL, van Balken V, Aalders TW, Schalken JA, et al. Intermediate cells in human prostate epithelium are enriched in proliferative inflammatory atrophy. Am J Pathol. 2003; 162(5):1529-37.spa
dc.relation.referencesDe Marzo AM, Nelson WG, Meeker AK, Coffey DS. Stem cell features of benign and malignant prostate epithelial cells. J Urol. 1998; 160(6 Pt 2): 2381-92.spa
dc.relation.referencesNakayama M, Bennett JC, Hicks JL, Epstein JI, Platz EA, Nelson WG. Hypermethylation of the human glutathione S-transferase-pi gene (GSTP1) CpG island is present in a subset of proliferative inflammatory atrophy lesions but not in normal or hyperplastic epithelium of the prostate: a detailed study using laser-capture microdissection. Am J Pathol. 2003; 163(3): 923-33.spa
dc.relation.referencesTomas D, Krušlina B, Rogatschb H, Schäferb G, Beliczaa M, Mikuzb G. Different types of atrophy in the prostate with and without adenocarcinoma. European Urology. 2007; 51(1): 98-103.spa
dc.relation.referencesDi Silverio F, Vincenzo Gentilea, Matteisb A, Mariottia G, Giuseppea V, Pastore Luigi PA. Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis. European Urology. 2003; 43(2):164-75.spa
dc.relation.referencesPostma R, Schroder FH, van der Kwast TH. Atrophy in prostate needle biopsy cores and its relationship to prostate cancer incidence in screened men. Urology. 2005; 65(4):745-9.spa
dc.relation.referencesPerletti G, Montanari E, Vral A, Gazzano G, Marras E. Inflammation, prostatitis, proliferative inflammatory atrophy: ‘Fertile ground’ for prostate cancer development? Molecular medicine reports. 2010; 3(1): 3-12.spa
dc.relation.referencesYildiz-Sezer S, Verdorfer I, Schäfer G, Rogatsch H, Bartsch G, Mikuz G. Assessment of aberrations on chromosome 8 in prostatic atrophy. BJU Int. 2006. 98(1):184-8.spa
dc.relation.referencesMacoska JA, Trybus TM, Wojno KJ. 8p22 loss concurrent with 8c gain is associated with poor outcome in prostate cancer. Urology. 2000;55(5):776-82.spa
dc.relation.referencesBethel CR, Faith D, Li X, Guan B, Hicks JL, Lan F. Decreased NKX3.1 protein expression in focal prostatic atrophy, prostatic intraepithelial neoplasia, and adenocarcinoma: association with gleason score and chromosome 8p deletion. Cancer Research. 2006;66(22): 10683-90.spa
dc.relation.referencesKoh CM, Bieberich CH, Dang CHV, Nelson WG, Yegnasubramanian S. MYC and Prostate Cancer. Genes & Cancer. 2010;1(6):617-28.spa
dc.relation.referencesGurel B, Iwata T, Koh ChM, Jenkins RB, Lan F, Dang ChV . Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis. Modern pathology. 2008; 21(9):1156-67.spa
dc.relation.referencesTsujimoto Y, Takayama H, Nonomura N, Okuyama A, Aozasa K. Postatrophic hyperplasia of the prostate in Japan: histologic and immunohistochemical features and p53 gene mutation analysis. The Prostate. 2002;52(4):279-87.spa
dc.relation.referencesKristiansen G. Diagnostic and prognostic molecular biomarkers for prostate cancer. Histopathology. 2012; 60(1):125-41.spa
dc.relation.referencesDe Marzo AM, Meeker AK, Esptein JI, Coffey DS. Prostate stem cell compartments: expression of the cell cycle inhibitor p27Kip1 in normal, hyperplastic, and neoplastic cells. Am J Pathol.1998;153(3): 911-9.spa
dc.relation.referencesWang W, Bergh A, Damber JE. Chronic inflammation in benign prostate hyperplasia is associated with focal upregulation of cyclooxygenase-2, Bcl-2, and cell proliferation in the glandular epithelium. The Prostate. 2004;61(1):60-72.spa
dc.relation.referencesWang W, Bergh A, Damber JE. Increased expression of CCAAT/enhancer-binding protein beta in proliferative inflammatory atrophy of the prostate: relation with the expression of COX-2, the androgen receptor, and presence of focal chronic inflammation. The Prostate. 2007; 67(11):1238-46.spa
dc.relation.referencesParsons JK, Nelson ChP, Cage WR, Nelson WG, Kensler TW, De Marzo AM. GSTA1 expression in normal, preneoplastic, and neoplastic human prostate tissue. The Prostate. 2001; 49(1): 30-7.spa
dc.relation.referencesBastian PJ, Yegnasubramanian S, Palapattua GS, Rogers CG, Linb X, De Marzo AM. Molecular biomarker in prostate cancer: the role of CpG island hypermethylation. European Urology. 2004; 46(6):698-708.spa
dc.relation.referencesNelson WG, De Marzo AM, Yegnasubramanian S. Epigenetic alterations in human prostate cancers. Endocrinology. 2009;150(9):3991-4002.spa
dc.relation.referencesBenedettini E, Nguyen P, Loda M. The pathogenesis of prostate cancer: from molecular to metabolic alterations. Diagnostic Histopathology. 2008;14(5):195-201.spa
dc.relation.referencesZha S, Gage GR, Sauvageot J, Saria EA, Putzi MJ, Ewing ChM. Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma. Cancer Research. 2001; 61(24):8617-23.spa
dc.relation.referencesZha S, Yegnasubramanianc V, Nelson WG, William B I, De Marzo AM. Cyclooxygenases in cancer: progress and perspective. Cancer Letters. 2004. 215(1):1-20.spa
dc.relation.referencesOrtega S, Malumbres M, Barbacid M. Cyclin D-dependent kinases, INK4 inhibitors and cancer. Biochimica et Biophysica Acta. 2002;1602(1):73-87.spa
dc.relation.referencesFaith D, Han S, Lee DK, Friedi A, Hicks JL, De Marzo AM. p16 Is upregulated in proliferative inflammatory atrophy of the prostate. The Prostate. 2005;65(1):73-82.spa
dc.relation.referencesBillis A, Freitas LL, Magna LA, Ubirajara F. Inflammatory atrophy on prostate needle biopsies: is there topographic relationship to cancer? Int Braz J Urol. 2007;33(3):355- 60.spa
dc.relation.referencesBrasil AA, Favaro WJ, Cagnon VH, Ferreira U, Billis A. Atrophy in specimens of radical prostatectomy: is there topographic relation to high-grade prostatic intraepithelial neoplasia or cancer? International Urology and Nephrology. 2011; 43(2):397-403.spa
dc.relation.referencesAsimakopoulos A, Miano R, Maurielo A, Costantini S, Pasqualetti P, Pasqualetti P, et al. Significance of focal proliferative atrophy lesions in prostate biopsy cores that test negative for prostate carcinoma. Urologic Oncology. 2011;29(6):690-7.spa
dc.rightsRevista Ciencias Biomédicas - 2020spa
dc.rights.accessrightsinfo:eu-repo/semantics/openAccessspa
dc.rights.coarhttp://purl.org/coar/access_right/c_abf2spa
dc.rights.urihttps://creativecommons.org/licenses/by-nc-sa/4.0/spa
dc.sourcehttps://revistas.unicartagena.edu.co/index.php/cbiomedicas/article/view/2892spa
dc.subjectAtrofiaspa
dc.subjectNeoplasia de la próstataspa
dc.subjectPróstata.spa
dc.titleAtrofia inflamatoria proliferativa: potencial lesión precursora de adenocarcinoma prostáticospa
dc.title.translatedAtrofia inflamatoria proliferativa: potencial lesión precursora de adenocarcinoma prostáticoeng
dc.typeArtículo de revistaspa
dc.type.coarhttp://purl.org/coar/resource_type/c_6501spa
dc.type.coarversionhttp://purl.org/coar/version/c_970fb48d4fbd8a85spa
dc.type.contentTextspa
dc.type.driverinfo:eu-repo/semantics/articlespa
dc.type.localJournal articleeng
dc.type.versioninfo:eu-repo/semantics/publishedVersionspa
dspace.entity.typePublication

Archivos

Datos de Contacto

Imagen Escudo Universidad de Cartagena

 

 

 

Línea de Atención

Línea Anticorrupción

Síguenos en: